Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Peripheral T-cell Lymphoma”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT05477264
What this trial is testing

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Who this might be right for
Lymphoma
Won Seog Kim 38
Large-scale testing (Phase 3)Looking for participantsNCT04365036
What this trial is testing

A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 207
Testing effectiveness (Phase 2)UnknownNCT04480099
What this trial is testing

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 96
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Large-scale testing (Phase 3)UnknownNCT03952572
What this trial is testing

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 244
Testing effectiveness (Phase 2)UnknownNCT04480125
What this trial is testing

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT00441025
What this trial is testing

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma
Mahidol University 4
Not applicableActive Not RecruitingNCT01787409
What this trial is testing

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more
Mayo Clinic 565
Large-scale testing (Phase 3)Looking for participantsNCT06947967
What this trial is testing

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd. 224
Testing effectiveness (Phase 2)Study completedNCT03246750
What this trial is testing

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
The Thai Lymphoma Study Group 34
Post-approval studies (Phase 4)UnknownNCT03631862
What this trial is testing

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University 100
Testing effectiveness (Phase 2)Study completedNCT00930605
What this trial is testing

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
King Chulalongkorn Memorial Hospital 16
Testing effectiveness (Phase 2)Looking for participantsNCT05675813
What this trial is testing

Genotype-guided Treatment in Newly Diagnosed PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 264
Large-scale testing (Phase 3)Study completedNCT00970385
What this trial is testing

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
University Hospital, Grenoble 95
Testing effectiveness (Phase 2)Ended earlyNCT02533323
What this trial is testing

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Large-scale testing (Phase 3)Looking for participantsNCT05931263
What this trial is testing

Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 104
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Not applicableUnknownNCT05896813
What this trial is testing

CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 30
Post-approval studies (Phase 4)UnknownNCT03071822
What this trial is testing

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
The University of Hong Kong 50
Testing effectiveness (Phase 2)UnknownNCT03154918
What this trial is testing

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sichuan University 60
Load More Results